RHYTHM BIOSCIENCES LIMITED — Capital/Financing Update 2021

Dec 12, 2021

==> picture [595 x 102] intentionally omitted <==

----- Start of picture text ----- ASX Announcement13 December 2021----- End of picture text -----

NOTICE UNDER SECTION 708A(5)(e) OF THE CORPORATIONS ACT 2001

• (a) The Company has issued 32,045 fully paid ordinary shares in the Company via the conversion of unlisted options.

• (b) The shares were issued without disclosure to investors under Part 6D.2 of the Corporations Act.

• (c)

  • As at the date of this notice, the Company has complied with:

  • the provisions of Chapter 2M of the Corporations Act, as they apply to the Company; and

  • section 674 of the Corporation Act.

• (d) As at the date of this notice, there is no 'excluded information' (within the meaning of sections 708A(7) and 708A(8) of the Corporations Act) required to be disclosed under section 708A(6)(e) of the Corporations Act.

Released with the authority of the Board.

==> picture [92 x 50] intentionally omitted <==

Adrien Wing Company Secretary

Australian Registered Address Level 2, 480 Collins Street Melbourne VIC 3000 Australia

Directors

Otto Buttula Executive Chairman Glenn Gilbert Managing Director Trevor Lockett Executive Director Louis Panaccio Non-Executive Director Eduardo Vom Non-Executive Director

Rhythm Biosciences Ltd ACN 619 459 335 ASX: RHY

T +61 3 9614 0600 E info@rhythmbio.com

www.rhythmbio.com